Patient Compliance Clinical Trial
— CORTEX-IIOfficial title:
Cognitive Regulation Training and Exercise (CORTEX)-II With Middle-Aged Adults
Verified date | December 2020 |
Source | University of Illinois at Urbana-Champaign |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this double-blinded, randomized controlled study is to compare CORTEX (Cognitive Regulation Training and Exercise), a multi-faceted, center- and home-delivered- general and exercise-specific-active and traditional computerized cognitive training (CT) program to an attention-control condition involving health and wellness informational videos. More specifically, the cognitive training group will emphasize dual-task abilities, working memory, and visual-spatial processing, as well as self-as-exerciser priming and self-certainty training. It is hypothesized that early intervention cognitive training will enhance use of self-regulatory strategies and self-efficacy and in turn, increase exercise adherence to and engagement in a 12-month aerobic and resistive exercise program at a local fitness facility. More positive improvements in cognitive and psychosocial functioning among participants in the CORTEX condition (relative to the Video Attention-Control condition, i.e., health educational videos), are also expected immediately following the cognitive training, and across time. Expectancies and knowledge of study purpose (blinding integrity) will also be measured and used to statistically adjust for any training differences.
Status | Completed |
Enrollment | 233 |
Est. completion date | October 10, 2020 |
Est. primary completion date | May 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years to 64 Years |
Eligibility | Inclusion Criteria: - Men and women - Low active for the past 3 months - 35 to 64 years old - Do NOT regularly play exergames (e.g., XBox Kinect, Playstation Move, Nintendo Wii) - Do NOT engage in "brain training" regularly (less than once per week) - Are NOT enrolled in another exercise program or cognitive training study - Able and willing to comply with the study length, testing, training and exercise program requirements - Lives within 20 miles of the fitness facility and UIUC research facility - Has reliable at-home Wi-Fi internet access and an available port for plugging in XBox console - Vision is at least 20/40 with glasses or contacts with no color blindness - Do NOT have depression (as defined by a score of 2 or less on the abbreviated Geriatric Depression Scale [GDS-5]) - Do NOT have cognitive impairment (as defined by a score of 21 or higher on the Telephone Interview Cognitive Survey [TICS]) Exclusion Criteria: - Previously involved in the first CORTEX trial - Currently involved in regular weekly cognitive training or another physical activity program or study (e.g., yoga, meditation) - Too active (as defined by regularly exercise 2 or more days per week for 30+ minutes over the past 3 months) - Incapable of performing moderately intensive aerobic exercise (must be able to complete basic movements, i.e., walking, jogging, jumping, side-stepping, throwing, kicking, punching, grabbing) without exacerbating a pre-existing condition caused by overuse, surgery, or other chronic condition - Unable or unwilling to comply to lab and home-based training and physical activity prescription - Unable to commit to full length of program - Unwilling to be randomized to one of two groups - Home residence exceeds 20 mile radius from fitness facility or unable to commute to and from fitness facility and UIUC campus - Do not have reliable at-home Wi-Fi internet access or a required port for plugging in Xbox - Uncorrectable vision (i.e., less than 20/40 with glasses or contacts with color blindness) - Depression as defined by GDS >2 - Cognitive impairment as defined by TICS < 21 |
Country | Name | City | State |
---|---|---|---|
United States | University of Illinois | Urbana | Illinois |
Lead Sponsor | Collaborator |
---|---|
University of Illinois at Urbana-Champaign | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Exercise self-regulation | Exercise self-regulation will be modeled within a latent variable framework. The change factor will be reflected by accumulated supervised and unsupervised class participation rates, total electronically-recorded visitations, averaged monthly Fitbit-derived step counts, and self-reported leisure-time exercise (via Godin Leisure-Time Questionnaire). Measures will be standardized as z-scores. The latent factor model will be adjusted for known covariates (age, gender, education level, training compliance [percentage of completed sessions] and injury/illness) when primary hypothesis of group effects is tested. There is always the possibility that attempts to analyze latent constructs will not converge as planned. In such a case, researchers will attempt to assess change across each behavioral outcome individually with a robust linear regression method, adjusting for multiple comparisons. | 12 months | |
Secondary | Dual task functioning (change) | Four separate heterogeneous dual task transfer assessments will involve auditory and/or visual stimuli. The tasks will progress from a focus on response to singularly-presented stimuli to dual task trials involving equally-prioritized responses (accuracy and quickness) to combinations of colors-letters, pictures-arrows, sounds-voices, and animals-planets. The percentage of incorrect response trials, accuracy, and reaction time will be the outcome measures for each of these tasks. Dual-task percent cost will then be calculated by the following equation: (dual task reaction time - single task reaction time) /single reaction time) x 100. Cost scores will be included as latent factor indicators in a structural equation model testing change from baseline to 1-month follow-up (post-intervention). Measures will be standardized as z-scores. | 1 month | |
Secondary | Memory functioning (change) | Again, from a latent factor perspective, multiple measures will be used to assess the construct of memory functioning, which will reflect overall working memory, spatial and episodic memory. Assessments will be utilized from the iPad-delivered NIH Toolbox, as well computerized assessments developed in E-Prime (e.g., Sternberg). Latent factor memory functioning change from baseline to 1-month follow-up (post-intervention) will be represented by total percent correct for each assessment at each time point. Measures will be standardized as z-scores. | 1 month | |
Secondary | Exercise self-efficacy (change) | Once again, from a latent factor perspective, multiple measures will be used to assess confidence that one can successfully walk longer distances (Self-Efficacy for Walking Scale), continue an exercise regimen (Exercise Self-Efficacy Scale), accumulate physical activity into one's life (Lifestyle Self-Efficacy Scale) and overcome barriers (Barriers Self-Efficacy Scale). An Exercise Self-Efficacy latent factor will be derived from equally-weighted latent factor indicators from each of the scales, and will be used to assess change in exercise-related efficacy beliefs from baseline to 1-month follow-up (post-intervention). Measures will be standardized as z-scores. | 1 month | |
Secondary | Physical activity self-regulatory strategy-use (change) | Participants' perceived use of exercise-specific self-regulatory strategies will be assessed with the multi-dimensional 12-item Physical Activity Self-Regulation Scale. Each of the 12 items will serve as the latent factor indicators for baseline and 1-month follow-up (post-intervention). | 1 month | |
Secondary | Exercise planning (change) | The 10-item Exercise Planning and Scheduling Scale will be used to assess change in exercise-specific planning behaviors from baseline to 1-month follow-up (post-intervention). | 1 month | |
Secondary | Memory strategy-use (change) | Again, from a latent factor framework, multiple self-report scales assessing memory strategy-use (subscale of Metamemory Questionnaire), memory self-efficacy (10-item Memory Self-Efficacy Scale), behavioral self-control (13-item Brief Self-Control Scale), affective and cognitive self-control (10-item Volitional Components Inventory) will be used to derive a latent factor to assess change in perceived Memory Strategy-Use from baseline to 1-month follow-up (post-intervention). Measures will be standardized as z-scores. | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03667911 -
Virtual Reality Videos in Improving Bowel Preparation Quality of Colonoscopy
|
N/A | |
Completed |
NCT05297188 -
The Effect of Ergonomic Sleep Mask Usage on Patients' Sleep Quality and Comfort
|
||
Completed |
NCT03264937 -
Social-software iMproving wARfarin Therapy
|
N/A | |
Completed |
NCT04291807 -
Video Assisted Education Before ERCP
|
N/A | |
Completed |
NCT02742740 -
Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials
|
N/A | |
Completed |
NCT03220204 -
Researching Emotions And Cardiac Health: Phase III
|
N/A | |
Completed |
NCT02669355 -
Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting
|
N/A | |
Completed |
NCT02756949 -
Smart Linkage-to-HIV Care Via a Smartphone App
|
N/A | |
Completed |
NCT03147716 -
Parent Engagement Package: Comparing Strategies for Engaging Parents Into Parenting Programs
|
N/A | |
Completed |
NCT01568515 -
Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students
|
Phase 0 | |
Recruiting |
NCT06092281 -
Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD
|
N/A | |
Completed |
NCT03125668 -
Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin
|
N/A | |
Recruiting |
NCT03753035 -
Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
|
||
Completed |
NCT05331820 -
The Influence of Weekly Reminders on Enhancing Patient Compliance in Patients With Fixed Orthodontic Treatment
|
N/A | |
Completed |
NCT02294019 -
Actual Use Trial of Ibuprofen 400 mg
|
Phase 3 | |
Not yet recruiting |
NCT02301923 -
Continuous Positive Airway Pressure (CPAP) Compliance in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT01897870 -
The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.
|
N/A | |
Completed |
NCT01559805 -
Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
|
N/A | |
Completed |
NCT01752595 -
The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment
|
N/A | |
Active, not recruiting |
NCT01454830 -
Tailored Intervention to Promote Positive Airway Pressure Adherence
|
Phase 1 |